An artificial pancreas (a closed-loop system) adjusts insulin automatically and represents a realistic treatment option for type 1 diabetes.14 The closed-loop control algorithm translates, in real-time, sensor glucose levels received from the glucose monitoring device and computes the amount of insulin to be delivered by the coupled insulin pump. The gene discussed is INS; the disease is type 1 diabetes mellitus.